William D. McCombe
Chief Financial Officer at Velo3D Inc.
Sits on 1 board. Last updated September 27, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Velo3D Inc., 3 years.
Velo3D Inc.
Director · Chief Financial Officer
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Aug 18, 2026 | Cytek Biosciences Inc. | Option exercise | +6,320 | — | — |
| Aug 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −2,111 | $4.67 | $9,858 |
| Aug 18, 2026 | Cytek Biosciences Inc. | Option exercise | +13,051 | — | — |
| Aug 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −4,392 | $4.67 | $20,511 |
| Aug 18, 2026 | Cytek Biosciences Inc. | Option exercise | +16,049 | — | — |
| Aug 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −5,401 | $4.67 | $25,223 |
| May 18, 2026 | Cytek Biosciences Inc. | Option exercise | +6,320 | — | — |
| May 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −2,268 | $3.55 | $8,051 |
| May 18, 2026 | Cytek Biosciences Inc. | Option exercise | +8,700 | — | — |
| May 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −3,122 | $3.55 | $11,083 |
| May 18, 2026 | Cytek Biosciences Inc. | Option exercise | +10,699 | — | — |
| May 18, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −3,839 | $3.55 | $13,628 |
| Mar 10, 2026 | Cytek Biosciences Inc. | Option exercise | +6,320 | — | — |
| Mar 10, 2026 | Cytek Biosciences Inc. | Shares withheld for tax | −2,603 | $4.23 | $11,011 |
| Mar 10, 2026 | Cytek Biosciences Inc. | Option exercise | +17,401 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.